Find News

Filter articles

Applied Filters

Showing 91 to 100 of 1072 results

Fed Circuit split decision denies Biogen’s bid to revive MS drug patent


The US Court of Appeals for the Federal Circuit has refused Biogen’s attempt to revive a key patent for its multiple sclerosis drug Tecfidera (dimethyl fumarate), leaving Mylan’s successful challenge intact. 

Court denies Sun Pharma’s bid to avoid trial

India, US25-11-2021

Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Bayer, Onyx drop Nexavar patent suit

US23-11-2021Muireann Bolger

Bayer Healthcare and Amgen subsidiary Onyx Pharmaceuticals have dropped a patent infringement suit against Dr Reddy’s over a planned generic version of cancer treatment Nexavar.

PTAB grants IPR of Regeneron Eylea patents

US11-11-2021Alex Baldwin

The US Patent Trial and Appeal Board will review the validity of two Regeneron Pharmaceuticals patents related to its Eylea (aflibercept) medication.

EPO upholds Bayer's Xarelto dosage patents

EU04-11-2021Alex Baldwin

Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office, the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto.

Pfizer fights approval of generic Ibrance


Pfizer is seeking to block a generic version of its cancer drug Ibrance from entering the market until the patent covering the drug expires in May 2036.

Azurity sues Bionpharma over newly issued patent

US19-10-2021Alex Baldwin

Azurity Pharmaceuticals has sued Massachusetts drug company Bionpharma, claiming that its generic of Azurity’s Epaned product infringes on a brand new patent.

AstraZeneca wins patent infringement case over Farxiga generic

US19-10-2021Alex Baldwin

AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.

Jazz Pharma accused of pay-for-delay deals over Xyrem

US14-10-2021Alex Baldwin

Molina Healthcare claims that Jazz Pharmaceuticals delayed generics of its flagship narcolepsy drug Xyrem and hiked the drug prices to increase profits when it was on the verge of bankruptcy.

Bayer, Meda sue Apotex over nasal spray

US12-10-2021Alex Baldwin

Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

Showing 91 to 100 of 1072 results